Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAutolus Therapeutics plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$0.26 | -$0.24 | -$0.25 |
| Q2 2026 | 5 | -$0.28 | -$0.23 | -$0.25 |
| Q3 2026 | 1 | -$0.25 | -$0.22 | -$0.23 |
| Q4 2026 | 1 | -$0.23 | -$0.21 | -$0.22 |
| Q1 2027 | 1 | -$0.22 | -$0.20 | -$0.21 |
| Q2 2027 | 1 | -$0.21 | -$0.18 | -$0.20 |
| Q3 2027 | 1 | -$0.20 | -$0.17 | -$0.18 |
| Q4 2027 | 1 | -$0.19 | -$0.16 | -$0.17 |
| Q1 2028 | 2 | -$0.21 | -$0.19 | -$0.20 |
| Q2 2028 | 2 | -$0.20 | -$0.18 | -$0.19 |
| Q3 2028 | 2 | -$0.19 | -$0.17 | -$0.18 |
| Q4 2028 | 2 | -$0.18 | -$0.16 | -$0.17 |
Autolus Therapeutics plc Earnings Date And Information
Autolus Therapeutics plc last posted its earnings results on Friday, March 27th, 2026. The company reported $-0.34 earnings per share for the quarter, missing analysts' consensus estimates of $-0.25993 by $0.08007. The company had revenue of 24.25 M for the quarter and had revenue of 75.56 M for the year. Autolus Therapeutics plc has generated $-1 earnings per share over the last year ($-1.08 diluted earnings per share) and currently has a price-to-earnings ratio of -1.58. Autolus Therapeutics plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Autolus Therapeutics plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/27/2026 | Q4 2025 | -$0.26 | -$0.34 | -0.08 | $23.92 M | $24.25 M |
| 11/12/2025 | Q3 2025 | -$0.23 | -$0.30 | -0.07 | $22.06 M | $21.19 M |
| 08/12/2025 | Q2 2025 | -$0.24 | -$0.18 | 0.06 | $13.24 M | $20.92 M |
| 05/08/2025 | Q1 2025 | -$0.24 | -$0.26 | -0.02 | $2.23 M | $8.98 M |
| 03/20/2025 | Q4 2024 | -$0.21 | -$0.10 | 0.11 | $2.89 M | $29.00 K |
| 11/12/2024 | Q3 2024 | -$0.21 | -$0.31 | -0.1 | $155.00 K | $0 |
| 08/08/2024 | Q2 2024 | -$0.19 | -$0.22 | -0.03 | $93.75 K | $0 |
| 05/17/2024 | Q1 2024 | -$0.10 | -$0.24 | -0.14 | $29.01 M | $10.09 M |
| 03/21/2024 | Q4 2023 | N/A | -$0.44 | N/A | N/A | $0 |
| 11/02/2023 | Q3 2023 | -$0.24 | -$0.26 | -0.02 | N/A | $406.00 K |
| 08/03/2023 | Q2 2023 | -$0.22 | -$0.26 | -0.04 | N/A | $0 |
| 05/04/2023 | Q1 2023 | -$0.28 | -$0.23 | 0.05 | N/A | $1.29 M |
| 03/07/2023 | Q4 2022 | -$0.31 | -$0.23 | 0.08 | N/A | $3.83 M |
| 11/03/2022 | Q3 2022 | -$0.46 | -$0.47 | -0.01 | N/A | $2.37 M |
| 06/30/2022 | Q2 2022 | N/A | -$0.46 | N/A | N/A | $0 |
| 05/05/2022 | Q1 2022 | -$0.51 | -$0.41 | 0.1 | N/A | $0 |
| 03/10/2022 | Q4 2021 | -$0.49 | -$0.57 | -0.08 | N/A | $180.00 K |
| 11/03/2021 | Q3 2021 | -$0.50 | -$0.47 | 0.03 | N/A | $236.00 K |
| 06/30/2021 | Q2 2021 | N/A | -$0.47 | N/A | N/A | $1.65 M |
| 05/06/2021 | Q1 2021 | -$0.62 | -$0.53 | 0.09 | N/A | $269.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Autolus Therapeutics plc Earnings: FAQ's
The conference call for Autolus Therapeutics plc's latest earnings report can be listened to online.
The conference call transcript for Autolus Therapeutics plc's latest earnings report can be read online.
Autolus Therapeutics plc (:AUTL) has a recorded annual revenue of $75.56 M.
Autolus Therapeutics plc (:AUTL) has a recorded net income of $-287,528,000.Autolus Therapeutics plc has generated $-1.08 earnings per share over the last four quarters.
Autolus Therapeutics plc (:AUTL) has a price-to-earnings ratio of -1.58 and price/earnings-to-growth ratio is 0.06.